Association of sVAP-1, sRAGE, and CML with lactation-induced insulin sensitivity in young non-diabetic healthy women

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1842-1847

  Klenovicsová, Kristína ^a,b   Krivošíková, Zora ^a   Gajdoš, Martin ^a   Šebeková, Katarína ^b  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Adhesion molecules; Advanced glycation; Insulin sensitivity; Lactation; SRAGE; SVAP 1

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; CREATININE; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BREAST FEEDING; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE UTILIZATION; HUMAN; INSULIN SENSITIVITY; LACTATION; MOTHER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SCORING SYSTEM; WEANING;

ADULT; AMINE OXIDASE (COPPER-CONTAINING); CELL ADHESION MOLECULES; COHORT STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LACTATION; LYSINE; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES;

EID: 79960629534     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.019     Document Type: Article

References (35)

1. Stuebe A.M., Rich-Edwards J.W. The reset hypothesis: lactation and maternal metabolism. Am J Perinatol 2009, 26:81-88.
2. Gunderson E.P., Lewis C.E., Wei G.S., Whitmer R.A., Quesenberry C.P., Sidney S. Lactation and changes in maternal metabolic risk factors. Obstet Gynecol 2007, 109:729-738.
3. Diniz J.M., Da Costa T.H. Independent of body adiposity, breast-feeding has a protective effect on glucose metabolism in young adult women. Br J Nutr 2004, 92:905-912.
4. Villegas R., Gao Y.T., Yang G., et al. Duration of breast-feeding and the incidence of type 2 diabetes mellitus in the Shanghai Women's Health Study. Diabetologia 2008, 51:258-266.
5. Schwarz E.B., Brown J.S., Creasman J.M., et al. Lactation and maternal risk of type 2 diabetes: a population-based study. Am J Med 2010, 123. 863.e1-863.e6.
6. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
7. Miyata T., Wada Y., Cai Z., et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997, 51:1170-1181.
8. Bierhaus A., Schiekofer S., Schwaninger M., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappa B. Diabetes 2001, 50:2792-2808.
9. Schmidt A.M., Yan S.D., Wautier J.L., Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999, 84:489-497.
10. Yonekura H., Yamamoto Y., Sakurai S., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003, 370:1097-1109.
11. Li H.Y., Wei J.N., Lin M.S., et al. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 2009, 404:149-153.
12. Li H.Y., Lin M.S., Wei J.N., et al. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects. Clin Chim Acta 2009, 403:97-101.
13. Lyles G.A., Chalmers J. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 1992, 31:1417-1424.
14. Abella A., Marti L., Camps M., et al. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes 2003, 52:1004-1013.
15. Uribarri J., Cai W., Peppa M., et al. Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007, 62:427-433.
16. Tan K.C., Shiu S.W., Wong Y., Tam X. Serum advanced glycation end products is associated with insulin resistance. Diabetes Metab Res Rev 2011, Epub ahead of print. 10.1002/dmrr.1188.
17. Tahara N., Yamagishi S.I., Matsui T., et al. Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects. Cardiovasc Ther 2010, Epub ahead of print. 10.1111/j.1755-5922.2010.00177.x.
18. Boor P., Celec P., Klenovicsová K., et al. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers. Clin Chim Acta 2010, 411:1034-1040.
19. Basta G., Sironi A.M., Lazzerini G., et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 2006, 91:4628-4634.
20. Koyama H., Yamamoto H., Nishizawa Y. Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases. Biomark Insights 2007, 2:331-339.
21. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
22. Kjos S.L., Henry O., Lee R.M., Buchanan T.A., Mishell D.R. The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 1993, 82:451-455.
23. Riviello C., Mello G., Jovanovic L.G. Breastfeeding and the basal insulin requirement in type 1 diabetic women. Endocr Pract 2009, 15:187-193.
24. Burnol A.F., Leturque A., Ferré P., Kande J., Girard J. Increased insulin sensitivity and responsiveness during lactation in rats. Am J Physiol 1986, 251:E537-E541.
25. Stuebe A.M., Kleinman K., Gillman M.W., Rifas-Shiman S.L., Gunderson E.P., Rich-Edwards J. Duration of lactation and maternal metabolism at 3 years postpartum. J Womens Health (Larchmt) 2010, 19:941-950.
26. Cassese A., Esposito I., Fiory F., et al. In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 2008, 283:36088-36099.
27. Unoki H., Bujo H., Yamagishi S., Takeuchi M., Imaizumi T., Saito Y. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2007, 76:236-244.
28. Puddu A., Storace D., Odetti P., Viviani G.L. Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem Biophys Res Commun 2010, 395:122-125.
29. Šebeková K., Somoza V. Dietary advanced glycation end products (AGEs) and their health effects-PRO. Mol Nutr Food Res 2007, 51:1079-1084.
30. Germanová A., Kouckỳ M., Hájek Z., Parízek A., Zima T., Kalousová M. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem 2010, 43:442-446.
31. Enrique-Tarancon G., Castan I., Morin N., et al. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells. Biochem J 2000, 350:171-180.
32. Stolen C.M., Madanat R., Marti L., et al. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. FASEB J 2004, 18:702-704.
33. Mészáros Z., Szombathy T., Raimondi L., Karádi I., Romics L., Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 1999, 48:113-117.
34. Szabova L., Yamada S.S., Birkedal-Hansen H., Holmbeck K. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland. J Cell Physiol 2005, 205:123-132.
35. Thornalley P.J. Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation end products in tissue damage. Novartis Found Symp 2007, 285:229-243.